Invention Grant
- Patent Title: Streptococcal C5A peptidase vaccine
- Patent Title (中): 链球菌C5A肽酶疫苗
-
Application No.: US11071041Application Date: 2005-03-03
-
Publication No.: US08440205B2Publication Date: 2013-05-14
- Inventor: Paul Patrick Cleary , Deborah K. Stafslien
- Applicant: Paul Patrick Cleary , Deborah K. Stafslien
- Applicant Address: US MN St. Paul
- Assignee: Regents of the University of Minnesota
- Current Assignee: Regents of the University of Minnesota
- Current Assignee Address: US MN St. Paul
- Agency: Viksnins Harris & Padys PLLP
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K39/02 ; A61K39/00 ; A61K38/00 ; C07K1/00

Abstract:
Novel vaccines for use against β-hemolytic Streptococcus colonization or infection are disclosed. The vaccines contain an immunogenic amount of a variant of streptococcal C5a peptidase (SCP). Also disclosed is a method of protecting a susceptible mammal against β-hemolytic Streptococcus colonization or infection by administering such a vaccine. Enzymatically inactive SCP, and polynucleotides encoding these SCP proteins are further disclosed.
Public/Granted literature
- US20060153879A1 Streptococcal C5a peptidase vaccine Public/Granted day:2006-07-13
Information query